1. Bae S, Park J, Jun W. Water extract from Salvia plebeia ameliorates progression of non-alcoholic fatty liver disease via inhibition of oxidative stress inflammation reaction. Journal of Functional Foods. 2024 Feb 1;113:106038.
2. Grinshpan LS, Eilat-Adar S, Ivancovsky-Wajcman D, Kariv R, Gillon-Keren M, Zelber-Sagi S. Ultra-processed food consumption and non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance: A systematic review. JHEP Reports. 2024 Jan 1;6(1):100964. [10.1016/j.jhepr.2023.100964 ][PMID]
3. Duan Y, Pan X, Luo J, Xiao X, Li J, Bestman PL, Luo M. Association of inflammatory cytokines with non-alcoholic fatty liver disease. Frontiers in immunology. 2022 May 6;13:880298. [10.3389/fimmu.2022.880298 ][PMID]
4. Sakurai Y, Kubota N, Yamauchi T, Kadowaki T. Role of insulin resistance in MAFLD. International journal of molecular sciences. 2021 Apr 16;22(8):4156. [10.3390/ijms22084156 ][PMID]
5. Zhu J, Wan X, Wang Y, Zhu K, Li C, Yu C, Li Y. Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study. Endocrine. 2017 Apr;56(1):208-11. [10.1007/s12020-016-1112-5 ][PMID]
6. Watt MJ, Miotto PM, De Nardo W, Montgomery MK. The liver as an endocrine organ—linking NAFLD and insulin resistance. Endocrine reviews. 2019 Oct;40(5):1367-93. [10.1210/er.2019-00034 ][PMID]
7. Reif S, Moschko S, Gar C, Ferrari U, Hesse N, Sommer NN, Seißler J, Lechner A. No independent association of circulating fetuin-a with insulin sensitivity in young women. Hormone and Metabolic Research. 2020 Nov;52(11):809-14. [10.1055/a-1216-4405 ][PMID]
8. Meex RC, Hoy AJ, Morris A, Brown RD, Lo JC, Burke M, Goode RJ, Kingwell BA, Kraakman MJ, Febbraio MA, Greve JW. Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism. Cell metabolism. 2015 Dec 1;22(6):1078-89. [10.1016/j.cmet.2015.09.023 ][PMID]
9. Ghalavand A, Ghobadi MR, Motamedi P, Delaramnasab M. Reduction of fetuin B in adaptation to pyramidal aerobic exercises and its role in modulating insulin resistance and serum aminotransferases in patients with type 2 diabetes. EBNESINA. 2023 Mar 10;25(1):13-20.
10.Alabdul Razzak I, Fares A, Stine JG, Trivedi HD. The role of exercise in steatotic liver diseases: an updated perspective. Liver International. 2025 Jan;45(1):e16220. [10.1111/liv.16220 ][PMID]
11.Stine JG, Long MT, Corey KE, Sallis RE, Allen AM, Armstrong MJ, Conroy DE, Cuthbertson DJ, Duarte-Rojo A, Hallsworth K, Hickman IJ. American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology communications. 2023 Apr 1;7(4):e0108. [10.1097/HC9.0000000000000108 ][PMID]
12.Malin SK, Mulya A, Fealy CE, Haus JM, Pagadala MR, Scelsi AR, Huang H, Flask CA, McCullough AJ, Kirwan JP. Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease. Journal of Applied Physiology. 2013 Oct 1;115(7):988-94. [10.1152/japplphysiol.00237.2013 ][PMID]
13.Zhang LY, Liu T, Teng YQ, Yao XY, Zhao TT, Lin LY, Jin QS, Jin YJ. Effect of a 12-week aerobic exercise training on serum fetuin-A and adipocytokine levels in type 2 diabetes. Experimental and Clinical Endocrinology & Diabetes. 2018 Sep;126(08):487-92. [10.1055/s-0043-115904 ][PMID]
14.Ramírez-Vélez R, García-Hermoso A, Hackney AC, Izquierdo M. Effects of exercise training on Fetuin-a in obese, type 2 diabetes and cardiovascular disease in adults and elderly: a systematic review and Meta-analysis. Lipids in health and disease. 2019 Jan 22;18(1):23. [10.1186/s12944-019-0962-2 ][PMID]
15.Nikbakht M. The effect of a period of cross-fit training on serum levels of fetuin-B and lipid profile in women with type 2 diabetes. Journal of Sport and Biomotor Sciences. 2021 Mar 10;25(25):57-66.
16.Hak PT, Hodzovic E, Hickey B. The nature and prevalence of injury during CrossFit training. The Journal of Strength & Conditioning Research. 2022 Mar 1. [10.1519/JSC.0000000000000318 ][PMID]
17.Rios M, Becker KM, Cardoso F, Pyne DB, Reis VM, Moreira-Gonçalves D, Fernandes RJ. Assessment of cardiorespiratory and metabolic contributions in an extreme intensity CrossFit® benchmark workout. Sensors. 2024 Jan 14;24(2):513. [10.3390/s24020513 ][PMID]
18.Hemmati Moghadam A, Rahmani Ghobadi M, SafiKhani H. The Effect of Six Weeks of High-Intensity CrossFit Training on Serum Asprosin, Body Fat Percentage and Insulin Resistance in Men with Type 2 Diabetes. Journal of Police Medicine. 2023 Apr;12(1):1-3.
19.Adams R. Revised physical activity readiness questionnaire. Canadian Family Physician. 1999 Apr;45:992. [PMID]
20.Ozhan B, Ersoy BE, Kiremitci S, Ozkol M, Taneli FA. Insulin sensitivity indices: fasting versus glucose-stimulated ındices in pediatric non-alcoholic fatty liver disease. Eur. Rev. Med. Pharmacol. Sci. 2015 Sep 1;19:3450-8. [PMID]
21.Fealy CE, Nieuwoudt S, Foucher JA, Scelsi AR, Malin SK, Pagadala M, Cruz LA, Li M, Rocco M, Burguera B, Kirwan JP. Functional high‐intensity exercise training ameliorates insulin resistance and cardiometabolic risk factors in type 2 diabetes. Experimental physiology. 2018 Jul;103(7):985-94. [10.1113/EP086844 ][PMID]
22.Jelleyman C, Yates T, O'Donovan G, Gray LJ, King JA, Khunti K, Davies MJ. The effects of high‐intensity interval training on glucose regulation and insulin resistance: a meta‐analysis. Obesity reviews. 2015 Nov;16(11):942-61. [10.1111/obr.12317 ][PMID]
23.Egan B, Sharples AP. Molecular responses to acute exercise and their relevance for adaptations in skeletal muscle to exercise training. Physiological reviews. 2023 Apr 25. [10.1152/physrev.00054.2021 ][PMID]
24.Ghalavand A, Ghobadi MR. Effect of Exercise and Insulin Signaling on Glucose Transporter Type 4 in Skeletal Muscles: A narrative review. Journal of Shahid Sadoughi University of Medical Sciences. 2023 Mar 27.
25.Javadikia M, Yazdi AB, Khajei R, Abadi MR. The effect of 8 weeks high-intensity interval training and portulaca oleracea supplement on serum level of TAC, MDA, CRP, TNF-α in rats with non-alcoholic fatty liver disease. Complementary Medicine Journal. 2023 Jan 10;12(4):13-21.
26. Fredrickson G, Barrow F, Dietsche K, Parthiban P, Khan S, Robert S, Demirchian M, Rhoades H, Wang H, Adeyi O, Revelo XS. Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH. Molecular Metabolism. 2021 Nov 1;53:101270. [10.1016/j.molmet.2021.101270 ][PMID]
27.Wang Y, Guo Y, Xu Y, Wang W, Zhuang S, Wang R, Xiao W. HIIT ameliorates inflammation and lipid metabolism by regulating macrophage polarization and mitochondrial dynamics in the liver of type 2 diabetes mellitus mice. Metabolites. 2022 Dec 21;13(1):14. [10.3390/metabo13010014 ][PMID]
28.Karami E, Rostamkhani F. The effects of high-intensity interval training on the expression of interleukin-10 and STAT3 genes in the intestinal tissue of rats affected by hepatic steatosis. Journal of Exercise & Organ Cross Talk. 2022 Dec 1;2(4):150-4.
29.Malheiro LF, Oliveira CA, Portela FS, Mercês ÉA, de Benedictis LM, de Benedictis JM, de Andrade EN, Magalhães AC, de Melo FF, da Silva Oliveira P, de Jesus Soares T. High-intensity interval training alleviates liver inflammation by regulating the TLR4/NF-κB signaling pathway and M1/M2 macrophage balance in female rats with cisplatin hepatotoxicity. Biochemical and Biophysical Research Communications. 2024 Nov 12;733:150712. [10.1016/j.bbrc.2024.150712 ][PMID]
30.Ghalavand A, Nasiri M, Kardan H, Azari BB, Dalaramnasab M, Dadvar N. The effect of a short period of aerobic training on serum Asprosin, glycemic control, and lipid profile in women with type 2 diabetes. International Journal of Basic Sciences in Medicine. 2024 Feb 26;9(1):10-4.
31.Liu S, Xiao J, Zhao Z, Wang M, Wang Y, Xin Y. Systematic review and meta-analysis of circulating fetuin-A levels in nonalcoholic fatty liver disease. Journal of Clinical and Translational Hepatology. 2020 Dec 9;9(1):3. [10.14218/JCTH.2020.00081 ][PMID]
32.Zhang P, Qi Z, Xu H, Zhou L, Zhao X, Zhong H, Zhou W, Fan B, Wu H, Ge J. Fetuin-A increases thrombosis risk in non-alcoholic fatty liver disease by binding to TLR-4 on platelets. Cardiovascular Research. 2025 Jun;121(7):1091-107. [10.1093/cvr/cvaf096 ][PMID]
